Products for Research Use Only
RegisterLogin

WEHI-P8

CAT: 0931-T207007-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T207007-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
WEHI-P8 is an orally active inhibitor targeting the coronavirus papain-like protease (PLpro) . It inhibits SARS-CoV-2 PLpro with an IC50 of 12 nM and demonstrates excellent cellular activity with an EC50 of 298 nM. Additionally, WEHI-P8 has protective effects in mice against prolonged lung and brain symptoms caused by SARS-CoV-2. This compound is applicable for research on post-COVID-19 syndrome.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T62582-01WEHI-150
T13338-01WEHI-9625
T212189-01WEHI-326
T206161-01WEHI-3773
T3997WEHI-345
T13337LWEHI-539
T13337-01WEHI-539 hydrochloride
T13335-01WEHI-345 analog
T38760Desmethyl-WEHI-345 analog
T22457-01WEHL-03

Alternative Products

CatalogName
HY-172350WEHI-P8
BA3493-10WEHI-345
HY-128777-01WEHI-9625
HY-175362WEHI-326
ABC-TC1283WEHI 3BD
ABL-TC0742WEHI-3b
C12441-1mgWEHI-539
ABC-TC1285WEHI-164
MBS5805264WEHI-150

Popular Products